Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL

Detalles Bibliográficos
Autores principales: Shi, Hui, Zheng, Peihao, Liu, Rui, Xu, Teng, Yang, Fan, Feng, Shaomei, Guo, Yuelu, Ma, Lixia, Liu, Haidi, Lei, Yang, Li, Ruiting, Deng, Biping, Hou, Shuling, Li, Yang, Zheng, Qinlong, Hu, Kai, Ke, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034568/
https://www.ncbi.nlm.nih.gov/pubmed/35901280
http://dx.doi.org/10.1182/bloodadvances.2021006845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034568/
https://www.ncbi.nlm.nih.gov/pubmed/35901280
http://dx.doi.org/10.1182/bloodadvances.2021006845

Ejemplares similares